Home/Pipeline/GUARDIAN Heart Registry

GUARDIAN Heart Registry

Heart Transplant Outcomes

Post-MarketActive

Key Facts

Indication
Heart Transplant Outcomes
Phase
Post-Market
Status
Active
Company

About Paragonix Technologies

Paragonix Technologies is a commercial-stage medical device company that has established a new standard of care in organ transplantation through its integrated preservation and logistics platform. Founded in 2010 and headquartered in Cambridge, Massachusetts, the company offers a suite of organ-specific transport devices that provide precise temperature control to mitigate cold ischemic injury, supported by a HIPAA-compliant digital app for case management. With over 10,000 donor organs preserved and support for more than 180 transplant centers globally, Paragonix leverages its large-scale GUARDIAN registries to generate real-world evidence, aiming to improve transplant outcomes and expand the viable donor pool. The company operates a business model combining device sales with digital services and clinical support.

View full company profile

Therapeutic Areas